One name that's starting to trend within range of triggering a major breakout trade is Optimer Pharmaceuticals ( OPTR), a biopharmaceutical company engaged in the development and commercialization of pharmaceutical products in the U.S. and Canada. This stock has been on fire so far in 2013, with shares up sharply by 72%.
If you take a look at the chart for Optimer Pharmaceuticals, you'll notice that this stock has been uptrending strong for the last few weeks, with shares trending higher from its low of $12.86 to its intraday high of $15.73 a share. During that uptrend, shares of OPTR have been mostly making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of OPTR within range of triggering a major breakout trade.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts